Laracy Justin C, Chan June L, Kodama Rich, Yan Judy, Raible Kevin M, Sepkowitz Kent, McVoy Lauren, Babady N Esther, Kamboj Mini
Infection Control, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Clin Infect Dis. 2025 Jun 4;80(5):969-974. doi: 10.1093/cid/ciaf018.
Urinary tract infections are prone to overdiagnosis, and reflex urine culture protocols offer a valuable opportunity for diagnostic stewardship in this arena. However, there is no recommended standard testing approach. Patients with cancer are often excluded from reflex urine culture protocols, especially if they are severely immunosuppressed or neutropenic. The aim of this study was to evaluate the performance characteristics of urine screening studies, including dipstick urinalysis for nitrite and leukocyte esterase and urine microscopy for white blood cell count, to detect significant pathogen growth.
A retrospective study of 58 098 urine cultures with a paired dipstick urinalysis with or without urine microscopy was performed at Memorial Sloan Kettering Cancer Center in New York City, evaluating data from 1 January 2018 to 31 December 2020. A dipstick urinalysis was considered negative only if leukocyte esterase and nitrite were undetected.
A negative dipstick urinalysis had a negative predictive value of 98% for clinically significant bacteriuria in voided urine and 95% for catheterized urine. Notably, a negative urine dipstick test screen maintained a high negative predictive value among patients with neutropenia and in those with antibiotic exposure before testing. Finally, the presence of pyuria ≥10 white blood cells per high-power field on urine microscopy offered negligible incremental diagnostic benefit in samples with a negative dipstick urinalysis.
Reflex urine culture protocols contingent upon a screening dipstick urinalysis are a safe and effective platform for diagnostic stewardship in patients with cancer including those with neutropenia.
尿路感染易于过度诊断,而反射性尿培养方案为该领域的诊断管理提供了宝贵机会。然而,目前尚无推荐的标准检测方法。癌症患者通常被排除在反射性尿培养方案之外,尤其是那些严重免疫抑制或中性粒细胞减少的患者。本研究的目的是评估尿液筛查研究的性能特征,包括用于检测亚硝酸盐和白细胞酯酶的尿试纸分析以及用于白细胞计数的尿显微镜检查,以检测显著的病原体生长。
在纽约市纪念斯隆凯特琳癌症中心对58098份尿培养样本进行了回顾性研究,同时进行了配对的尿试纸分析(有或无尿显微镜检查),评估了2018年1月1日至2020年12月31日的数据。仅当未检测到白细胞酯酶和亚硝酸盐时,尿试纸分析才被视为阴性。
阴性尿试纸分析对排尿尿液中具有临床意义的菌尿的阴性预测值为98%,对导尿尿液的阴性预测值为95%。值得注意的是,阴性尿试纸检测筛查在中性粒细胞减少患者和检测前有抗生素暴露的患者中保持了较高的阴性预测值。最后,在尿试纸分析为阴性的样本中,尿显微镜检查每高倍视野脓尿≥10个白细胞对诊断的增量益处可忽略不计。
基于筛查尿试纸分析的反射性尿培养方案是癌症患者(包括中性粒细胞减少患者)诊断管理的安全有效平台。